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ObjectiveThe aim of this study was to use molecular typing of MDR and pan-susceptible
clinical isolates ofMycobacterium tuberculosis to increase the understanding of the transmis-
sion patterns and possible differences between the strains causing susceptible and drug-
resistant tuberculosis.
Study population and methods: Consecutive isolates from pulmonary TB patients in Minsk
were collected at the Belarusian National Reference Laboratory. Isolates found to be either
pan-susceptible or MDR were included in the study, which totally comprised 81 MDR and 82
pan-susceptible clinical isolates. All isolates were characterized by spoligotyping. The
major clusters were characterized using sequencing of the pncA gene.
Results: Three out of four MDR cases were caused by one out of two drug-resistant clones ofM.
tuberculosisbelonging totheBeijingandT1genotypes, respectively.AsingleT1clone,SITNo. 266,
foundexclusively in theMDRcohort,was shown to causeno less than 30% of allMDR-TB cases.
Discussion: The findings indicate that themajor cause of MDR-TB inMinsk is an ongoing transmission
of certain already resistant M. tuberculosis strains.
Conclusion: The significant transmission of MDR-TB in Minsk underlines the urgent need for
strengthened infection control measures to limit the transmission in order to better control
MDR-TB.
 2013 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction of these are found in India or China, but it is clearly docu-Multidrug resistant tuberculosis (MDR-TB) is a severe threat to
effective TB-control as well as to successful treatment of the
individual patients. It is estimated by the WHO that globally
more than 500,000 TB patients are infected with strains resis-
tant to the most effective anti-TB drugs–rifampicin (RIF) and
isoniazid (INH) – and thus classified as MDR-TB cases. Most-African Society for Myco
.
offner).mented [1] that the highest incidence with up to around
20% of new and 60% of re-treatment cases is to be found in
Eastern Europe and especially in some of the countries of
the former Soviet Union (USSR).
Belarus, a country in the western part of the former USSR
and neighbor of the EU countries Poland, Latvia and Lithuania,
is no exception. Even though the reported TB incidence (45/bacteriology. Published by Elsevier Ltd. All rights reserved.
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and increasing level of MDR-TB causes severe concerns from
a public health perspective and constitutes a very demanding
challenge for the national TB-control program. The drug resis-
tance survey (DRS) carried out in the city of Minsk from
November 2009 to December 2010 showed the highest ever re-
ported incidence of MDR-TB. Almost 1 out of 2 (48%) of all
infectious, smear-positive, pulmonary TB patients was shown
to be infected with a MDR-TB strain. Both newly diagnosed
and earlier treated patients had an outstanding highMDR inci-
dence, 35.3% and 76.5%, respectively [2]. More recently, a
nationwide survey was performed to investigate whether the
high MDR incidencewas limited to the capital or a more wide-
spread problem. The results showed that theMDR-TB problem
in Belarus iswidely spread throughout the entire country [3]. It
should be understood that this high prevalence of MDR-TB is
not a problem limited to a certain city or country. Unpublished
information from other parts of the former USSR indicates a
broad problem with a high and increasing incidence of MDR-
TB in various settings.
It is well documented that certain clones of resistantMyco-
bacterium tuberculosis strains are responsible for a significant
proportion of the overall MDR-TB problem in Eastern Europe.
Most often these clones belong to the so-called Beijing family
of TB strains [4].
This study was the first attempt to increase the under-
standing of the M. tuberculosis strains responsible for the drug
resistant TB in Belarus and its transmission. Pulmonary iso-
lates from 81 MDR-TB patients in Minsk city were character-
ized by molecular strain typing, and the genotypes and level
of clustering found were compared with a corresponding
number of pan-susceptible clinical isolates.
As a first step, spoligotyping was used to identify clusters
and the different geno-families of the studied strains. To fur-
ther characterize the major spoligo-clusters seen in MDR-TB,
the pncA gene – the gene where mutations related to resis-
tance to the drug pyrazinamid (PZA) are found – was se-
quenced. In selected cases, the results were confirmed with
MIRU/VNTR. The use of this sequencing for molecular epide-
miology of PZA-resistant M. tuberculosis strains is an interest-
ing option since the resistance-related point mutations are
scattered all over the pncA gene with no specific mutations
being commonly found [5].Study population and methods
Consecutive isolates from culture-verified cases of pulmonary
TB in Minsk were collected between 2009 and 2010 at the
Belarusian National Reference Laboratory (NRL) in Minsk. Iso-
lates found to be either susceptible to all tested first-line
drugs (RIF, INH, streptomycin and ethambutol) or MDR (resis-
tant to at least RIF and INH) were included in the study. The
study totally comprised 163 clinical isolates from patients
with pulmonary TB in Minsk city, 81 isolates being MDR and
82 pan-susceptible.
All strains were isolated at the Belarusian NRL in Minsk on
Lowenstein–Jensen (LJ) medium and identified with standard
biochemical tests. The in vitro susceptibility testing (DST) was
carried out with the absolute concentration method on LJmedium with the following critical concentrations: INH
1 mg/L, RIF 40 mg/L, ethambutol 2 mg/L and streptomycin
4 mg/L. DST at the NRL in Minsk was externally quality as-
sured by the WHO Supranational Reference Laboratory at
the Swedish Institute for Communicable Disease Control
(SMI) in Stockholm.
The molecular characterization of the isolates was carried
out at SMI to identify clusters and the different geno-families
of the M. tuberculosis strains.
All isolates were sub-cultured on LJ medium at SMI. For
spoligotyping, mycobacterial lysates were prepared by re-sus-
pending two 10 ll loops of bacteria in 250 ll of 1· TE buffer.
After heat-killing the bacteria at 80 C for one hour, the sus-
pensions were centrifuged at 13,000 rpm for two minutes.
The supernatants were discarded and the pellets re-sus-
pended in 500 ll of 150 mMNaCl. This centrifugation and sus-
pension steps were repeated. The final pellet was then
dissolved in 25 ll of 1· TE buffer.
Thereafter, all isolates were genotyped with spoligotyping
according to the standard protocol [6] using a commercial kit
(Isogen Bioscience, BV Maarsen, The Netherlands). Briefly, the
DR region of the TB genome was amplified using primers DRa
and DRb, and the amplified biotinylated products hybridized
to a set of 43 oligonucleotides covalently bound to a mem-
brane. The hybridized PCR products were then incubatedwith
streptavidin–peroxidase conjugate and the membrane ex-
posed to chemo luminescence (Amersham ECL DirectTM Nu-
cleic Acid Labeling and Detection System, GE Healthcare
Limited, UK) and exposed to X-ray film (Amersham Hyper-
filmTM ECL, GE Healthcare Limited, UK) according to the man-
ufacturer’s instruction. The X-ray film was developed using
standard photochemical procedures after 20 min exposure.
The DNA extracts of the M. tuberculosis reference strain
H37Rv and of Mycobacterium bovis BCG were used as controls.
The patterns obtained were analyzed using Bionumerics
software version 5.1 (Applied Maths, Belgium). A cluster was
defined as two or more strains sharing identical spoligotyping
patterns. Spoligotypes in binary format were converted to an
octal code for comparison with the SITVIT2 proprietary data-
base of the Pasteur Institute of Guadeloupe.
The octal codes found were entered in the SITVIT2 data-
base, which is an updated version of the previously released
SpolDB4 database [7]. In this database, SIT (Spoligotype Inter-
national Type) designates spoligotypes shared by two or more
patient isolates included in the database. Major phylogenetic
clades were assigned according to signatures provided in the
database, which defined 62 genetic lineages/sub-lineages.
The SITVIT2 contains more than 3000 SITs with global geno-
typing information on about 74,000 M. tuberculosis isolates
from over 160 countries of origin.
The pncA gene was sequenced in 76 MDR and 78 pan-sus-
ceptible isolates as earlier described [5]. Confirmatory MIRU/
VNTR analysis was performed in selected strains in the Bei-
jing and T1 clusters of MDR-TB isolates.Results
Both the proportion of strains in a cluster (28% vs 16%), and
the size of the largest clusters (42% vs 30%), were higher
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TB isolates, two major clones, a specific T1 clone (SIT No.
266) and the Beijing clone (SIT No. 001), were most prevalent.
These two were shown to cause 31% and 42% of all MDR-TB
cases respectively. Among the pan-susceptible isolates, only
small clusters of strains were seen with the exception of the
Beijing type isolates (SIT No. 001) found in 30% of the cases.
One more uncommon Beijing spoligotype (SIT No. 265) was
also detected in susceptible isolates. A difference was ob-
served also in the proportion of strains with unique patterns;
among the MDR isolates, only 13 of 81 isolates (16%) had a un-
ique pattern, compared with 23/82 (28%) for the pan-suscepti-
ble strains. The spoligotypes detected in the present study
were compared with the SITVIT2 database, where most of
the isolates could be identified as one of the lineages already
recorded. For both the MDR and the susceptible group, most
isolates were shown to belong to the Beijing family, seen in
33/81 (40.7%) and 26/82 (31.7%) respectively. Beside the Beijing
geno-family, the T1 family was most commonly seen and
identified in 30/81 (37.0%) and 16/82 (19.5%) of resistant and
susceptible cases respectively. A statistical significant associ-
ation to MDR-TB was demonstrated for the T1 type with the
Fisher’s exact test (p-value 0.0151), but not for the Beijing fam-
ily (p-value 0.2564).Table 1 – Lineages of MDR and susceptible M. tuberculosis
isolates from Minsk.
Lineage MDR strains Susceptible strains
No. % No. %
Beijing 33 40.7 26 31.7
T1 30 37.0 16 19.5
SIT No. 266 25 30.9 0 0
LAM 9 6 7.4 4 4.9
H1 0 0 4 4.9
T2 0 0 5 6.0
Manu 2 2 2.5 0 0
H4 2 2.5 1 1.2
U 2 2.5 3 3.7
T5_RUS1 1 1.2 2 2.4
T4_CEU1 0 0 2 2.4
Others 2 2.5 4 4.9
Not earlier reported 3 3.7 15 18.3
Total 81 100 82 100Discussion
The high proportion of strains in a cluster and the large cluster
size seen in this study clearly indicate a pronounced ongoing
transmissionof drug resistantTBandespecially of certaindrug
resistant clones of M. tuberculosis. The high transmission of
MDR-TB strains was further supported by the fact that unique
patterns were much more rarely seen in MDR isolates com-
pared with isolates from patients with pan-susceptible TB.
It was remarkable that among all T1 isolates the most fre-
quent spoligotype (SIT No. 266) was exclusively seen in MDR-
TB. A clear majority of all T1 MDR isolates had this specific
spoligopattern, 25/30 (83.3%), but it was not seen in a single
case of pan-susceptible TB. This cluster in itself explains the
significant difference observed for T1 isolates between MDR
and susceptible M. tuberculosis isolates.
This study further investigated this finding, and since de-
tailed information on clustering is not possible using spoligo-
typing as the sole method, it was decided to compare the T1
and Beijing family clones of the MDR-TB isolates by examina-
tion of the presence and distribution of pncA gene mutations.
The results obtained clearly demonstrated a difference be-
tween these two major spoligo-clones. All 22 tested strains
in the SIT No. 266 cluster had the same specific pncAmutation
(Asp94Gly) and constituted a true and very closely related
cluster. This is in contrast with the MDR Beijing spoligo-clus-
ter SIT No. 001, where several different pncA patterns were
seen among the tested isolates reflecting a much more heter-
ogeneous group of isolates. The largest cluster detected in
this group comprised eight Beijing strains with an identical
pncA mutation (Trp68Gly) showing a sub-cluster of highly re-
lated strains. This difference between the SIT No. 266 and SIT
No. 001 clusters was further confirmed in selected cases by
MIRU/VNTR (data not shown).Finally, it can be noted that the spoligotype pattern ob-
tained in 78/81 (96.3%) MDR isolates could be found in the
international database, while non-reported patterns were
much more commonly seen among the susceptible strains
15/82 (18.3%).
Patient’s records were analyzed to investigate if a common
source of infection or an epidemiological link could be identi-
fied among the 25MDR-TB patientswith the strongly homoge-
neous T1 SIT No. 266 clone. No such source or any common
epidemiological connection could be identified. The patients
comprised of 19 men and six women were born between
1946 and 1992, all 20 for whom HIV-status were known were
HIV-negative. Three men had a history of imprisonment.
The lack of a detectable link between these 25 individuals sug-
gests that this clone is not restricted to a single epidemiologi-
cal closely linked outbreak, but rather represents a widely
transmitted resistant clone, frequently seen in and causing
new cases of MDR-TB in Minsk city. This specific T1 strain
was earlier reported only rarely in the Spol DB 4 database, iso-
lated mainly in Russia (10 cases), but also in the USA (2 cases),
as well as Latvia and Algeria with 1 isolate each. For the other
SIT types identified, the actual numbers of observations were
too low to draw any conclusions. Some, e.g. the H1 and T2
types, were seen only in susceptible isolates, while the two
MANU type isolateswere recognized only among the MDR iso-
lates (Table 1). The most prevalent spoligotypes for the MDR
and susceptible isolates respectively are shown in Fig. 1.
The high prevalence of the Beijing genotype found in this
study, altogether 59/163 isolates (36.2%), as well as the con-
nection between the Beijing genotype and MDR-TB, is well
in line with earlier reports from the former USSR showing a
high overall prevalence of Beijing TB: e.g., 34% in the Ukraine
[8], 49% in Murmansk [9], 66% in Moscow [10], 50% in St.
Petersburg [11], 46% in Kaliningrad [4], 42% in Estonia [12],
and 54% in Latvia [13]. Regarding the T1-family, this is on
the other hand a new finding, not earlier reported as such
an important geno family, and especially the presence of a
specific clone (SIT No. 266) restricted to the MDR cases was
a totally new and unexpected finding.
SIT Spoligotype Description Octal Number 
Number 
(%), 
resistant 
strains 
Number 
(%), 
susceptible
strains 
Clade* 
1 000000000003771 33 (40.7) 25 (30.5) Beijing 
266 7757400037607 71 25 (30,9) 0 (0) T1 
53 777777777760771 1 (1.2) 12 (14.6) T1 
42 777777607760771 5 (6.1) 4 (4.8) LAM9 
47 777777774020771 0 (0) 4 (4.8) H1 
52 777777777760731 3 (3.7) 0 (0) T2 
254 7777600077607 71 1 (1.2) 2 (2.4) T5_RUS1
39 7777773477604 71 0 (0) 2 (2.4) T4_CEU1
118 777767777760771 0 (0) 2 (2.4) T2 
1482 7757400037637 71 2 (2.5) 0 (0) Manu2 
* Clade designations according to SITVIT2 using revised SpolDB4 rules 
Fig. 1 – Description of the most prevalent spoligotypes in Minsk. Here showing the isolates belonging to the largest clusters
among the samples that were matching a preexisting shared type in the SITVIT2 database.
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 2 ( 2 0 1 3 ) 1 9 4 –1 9 8 197The results of a molecular characterization of MDR-TB iso-
lates compared with fully susceptible strains can reveal infor-
mation useful for the national TB control program. The result
of this study from Belarus clearly demonstrated differences in
the population structure of strains isolated from patients with
MDR- and pan-susceptible TB. More importantly, a very pro-
nounced ongoing transmission of MDR-TB strains belonging
to the T1 and Beijing families was also found to be responsible
for a majority of all resistant cases in Minsk city. This finding
highlights the need for a strengthened infection control to limit
transmission of already resistant isolates ofM. tuberculosis.
It is clear that most of the MDR problem today in Minsk,
where almost every second patient with infectious TB is carry-
ing a MDR-TB strain [2], is related to transmission and insuffi-
cient infection control rather than poor treatment/adherence
causing many additional cases of acquired MDR-TB.
Apart from revealing important epidemiological informa-
tion, the sequencing of the pncA gene also indicates the level
of resistance to PZA, since these mutations in a very strong
majority of cases are related to such resistance. Almost 80%
of all studied MDR-TB isolates carried pncA mutations, which
suggest an overall level of PZA resistance in the order of 75%.
In contrast, over 90% of susceptible isolates showed wild type
pncA sequences indicating PZA susceptibility. Some of the few
mutations detected in PZA susceptible strains are silent or
known not to confer PZA resistance.
In summary it can be concluded that this study demon-
strated a high degree of clustering and the presence of large
clusters among clinical isolates from MDR-TB patients. This
indicates that the major cause of MDR-TB in Minsk is an
ongoing transmission of already drug-resistantM. tuberculosisstrains belonging to a limited number of specific clones rather
than the independent development of MDR-TB in a substan-
tial number of patients, initially infectedwith pan-susceptible
strains. As expected, the Beijing strains were prevalent, but
also the T1 family of M. tuberculosis strains were shown to
be responsible for a large portion of all MDR-TB cases in
Minsk city. Using sequencing of the pncA gene, the Beijing
cluster could be further divided into several sub-clusters,
while a specific T1 clone (SIT No. 266) was confirmed to be
one strictly homogenous cluster responsible for almost one
third (25/81) of the MDR cases examined.
Early detection of cases with resistant TB is of crucial
importance to make possible timely modification of treat-
ment to effective drug combinations and directed infection
control measures to limit further transmission of MDR-TB.
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